Jenburkt Pharmaceuticals Limited (JENBURPH.BO)
INR 1285.0
(-2.26%)
INR 1285.0
(-2.26%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.65 Billion INR | 16.42% |
| 2022 | 1.41 Billion INR | -0.8% |
| 2021 | 1.42 Billion INR | 17.96% |
| 2020 | 1.21 Billion INR | 16.18% |
| 2019 | 1.04 Billion INR | 1.44% |
| 2018 | 1.02 Billion INR | 32.73% |
| 2017 | 774.71 Million INR | 1.4% |
| 2016 | 764.03 Million INR | 30.47% |
| 2015 | 585.58 Million INR | -3.77% |
| 2014 | 608.52 Million INR | 38.28% |
| 2013 | 440.06 Million INR | -10.1% |
| 2012 | 489.52 Million INR | 21.4% |
| 2011 | 403.22 Million INR | 12.54% |
| 2010 | 358.31 Million INR | 34.58% |
| 2009 | 266.25 Million INR | 3.32% |
| 2008 | 257.68 Million INR | 0.81% |
| 2007 | 255.62 Million INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 FY | 1.65 Billion INR | 16.42% |
| 2023 Q4 | 1.65 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 1.49 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 1.46 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 1.41 Billion INR | 0.0% |
| 2022 FY | 1.41 Billion INR | -0.8% |
| 2021 Q4 | 1.42 Billion INR | 0.0% |
| 2021 Q2 | 1.3 Billion INR | 0.0% |
| 2021 FY | 1.42 Billion INR | 17.96% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q4 | 1.21 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 1.21 Billion INR | 16.18% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 1.1 Billion INR | 0.0% |
| 2019 FY | 1.04 Billion INR | 1.44% |
| 2019 Q4 | 1.04 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q2 | 1.01 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 FY | 1.02 Billion INR | 32.73% |
| 2018 Q4 | 1.02 Billion INR | 0.0% |
| 2018 Q2 | 859.75 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q4 | 774.71 Million INR | 0.0% |
| 2017 Q2 | 757.65 Million INR | 0.0% |
| 2017 FY | 774.71 Million INR | 1.4% |
| 2016 Q2 | 640.99 Million INR | 0.0% |
| 2016 FY | 764.03 Million INR | 30.47% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q4 | 764.03 Million INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2015 Q2 | 575.27 Million INR | 0.0% |
| 2015 FY | 585.58 Million INR | -3.77% |
| 2015 Q4 | 585.58 Million INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q1 | - INR | -100.0% |
| 2014 Q2 | 591.8 Million INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 FY | 608.52 Million INR | 38.28% |
| 2014 Q4 | 608.52 Million INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2013 Q4 | 440.06 Million INR | 0.0% |
| 2013 Q2 | 545.8 Million INR | 0.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 FY | 440.06 Million INR | -10.1% |
| 2013 Q3 | - INR | -100.0% |
| 2012 FY | 489.52 Million INR | 21.4% |
| 2012 Q4 | 489.52 Million INR | 0.0% |
| 2011 Q4 | 403.22 Million INR | 0.0% |
| 2011 FY | 403.22 Million INR | 12.54% |
| 2010 FY | 358.31 Million INR | 34.58% |
| 2009 FY | 266.25 Million INR | 3.32% |
| 2008 FY | 257.68 Million INR | 0.81% |
| 2007 FY | 255.62 Million INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 33.74 Million INR | -4792.848% |
| KIMIA BIOSCIENCES LIMITED | 999.66 Million INR | -65.155% |
| SHELTER PHARMA LIMITED | 379.14 Million INR | -335.448% |
| Vasundhara Rasayans Limited | 373.03 Million INR | -342.59% |
| Sunil Healthcare Limited | 1.58 Billion INR | -4.164% |
| Chemo Pharma Laboratories Limited | 130.15 Million INR | -1168.512% |
| MedPlus Health Services Limited | 30.04 Billion INR | 94.505% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1.88 Billion INR | 12.483% |
| Patidar Buildcon Limited | 94.27 Million INR | -1651.235% |
| Roopa Industries Limited | 647.82 Million INR | -154.853% |
| Smruthi Organics Limited | 1.18 Billion INR | -39.689% |
| Trident Lifeline Limited | 870.76 Million INR | -89.603% |
| PANJON LTD. | 173.91 Million INR | -849.327% |
| Pharmaids Pharmaceuticals Limited | 913.4 Million INR | -80.751% |
| Gujarat Terce Laboratories Limited | 232.73 Million INR | -609.388% |
| TIAAN CONSUMER LIMITED | 95.12 Million INR | -1635.623% |
| Anuh Pharma Limited | 4.45 Billion INR | 62.956% |
| Crestchem Limited | 71.44 Million INR | -2210.957% |
| Emmessar Biotech & Nutrition Limited | 87.42 Million INR | -1788.383% |
| Sandu Pharmaceuticals Limited | 524.14 Million INR | -214.986% |
| Tyche Industries Limited | 1.36 Billion INR | -20.599% |
| Fredun Pharmaceuticals Limited | 3.07 Billion INR | 46.326% |
| Trimurthi Limited | 73.64 Million INR | -2141.704% |
| Shukra Pharmaceuticals Limited | 778.37 Million INR | -112.109% |
| Norris Medicines Limited | 141.87 Million INR | -1063.712% |
| Zenlabs Ethica Limited | 402.58 Million INR | -310.099% |
| Vikram Thermo (India) Limited | 1.42 Billion INR | -15.717% |
| ANG Lifesciences India Limited | 2.42 Billion INR | 31.9% |
| Parmax Pharma Limited | 176.12 Million INR | -837.392% |
| Veerhealth Care Limited | 281.16 Million INR | -487.191% |
| Deccan Health Care Limited | 1.08 Billion INR | -52.802% |
| SUDARSHAN PHARMA INDUSTRIES LI | 2.83 Billion INR | 41.687% |
| Makers Laboratories Limited | 1.61 Billion INR | -2.384% |
| Lactose (India) Limited | 1 Billion INR | -63.889% |
| OXYGENTA PHARMACEUTICAL LIMITE | 631.92 Million INR | -161.266% |
| Zenith Healthcare Limited | 97.41 Million INR | -1594.839% |
| Sanjivani Paranteral Limited. | 434.05 Million INR | -280.367% |
| Bacil Pharma Limited | 13.26 Million INR | -12349.996% |
| PRAVEG LIMITED | 3.64 Billion INR | 54.716% |
| Denis Chem Lab Limited | 1.09 Billion INR | -50.984% |
| Kwality Pharmaceuticals Limited | 3.94 Billion INR | 58.119% |
| Colinz Laboratories Limited | 113.59 Million INR | -1353.417% |
| Godavari Drugs Limited | 1.34 Billion INR | -22.52% |
| SHAMROCK INDUSTRIAL CO.LTD. | 17.6 Million INR | -9280.115% |
| Zenotech Laboratories Limited | 1.06 Billion INR | -55.451% |
| Panchsheel Organics Limited | 1.59 Billion INR | -3.8% |
| Shree Ganesh Remedies Limited | 1.7 Billion INR | 3.414% |
| Vivanza Biosciences Limited | 195.01 Million INR | -746.603% |
| Phaarmasia Limited | 314.47 Million INR | -424.995% |
| Sastasundar Ventures Limited | 11.49 Billion INR | 85.638% |
| Medi-Caps Limited | 1.27 Billion INR | -29.709% |
| DECIPHER LABS LIMITED | 336.33 Million INR | -390.884% |
| Gujarat Themis Biosyn Limited | 2.21 Billion INR | 25.333% |
| Ambalal Sarabhai Enterprises Limited | 2.5 Billion INR | 34.02% |
| Mercury Laboratories Limited | 679.57 Million INR | -142.945% |
| Gennex Laboratories Limited | 2.29 Billion INR | 28.213% |
| BDH Industries Limited | 934.11 Million INR | -76.745% |
| Coral Laboratories Limited | 2.05 Billion INR | 19.73% |
| Concord Drugs Limited | 588.06 Million INR | -180.751% |
| Bharat Parenterals Limited | 5.03 Billion INR | 67.231% |
| Beryl Drugs Limited | 174.86 Million INR | -844.132% |
| Vista Pharmaceuticals Limited | 579.79 Million INR | -184.757% |
| Evoq Remedies Limited | 368.61 Million INR | -347.897% |
| Add-Shop E-Retail Limited | 1.25 Billion INR | -31.079% |
| Transchem Limited | 763.18 Million INR | -116.331% |
| Ishita Drugs and Industries Limited | 108.08 Million INR | -1427.468% |
| Parnax Lab Limited | 1.88 Billion INR | 12.537% |
| Source Natural Foods and Herbal Supplements Limited | 236.5 Million INR | -598.074% |
| Kerala Ayurveda Limited | 1.4 Billion INR | -17.177% |
| Cian Healthcare Limited | 1.61 Billion INR | -2.434% |
| Trinity League India Limited | 32.38 Million INR | -4997.863% |
| Syschem (India) Limited | 1.64 Billion INR | -0.653% |
| KOBO BIOTECH LIMITED | 713.93 Million INR | -131.253% |
| Natural Capsules Limited | 3.76 Billion INR | 56.152% |
| Auro Laboratories Limited | 852.67 Million INR | -93.624% |